Albert Coma-Cros
Fortuna: 676 102 $ al 30/06/2026
Fortuna: 676 102 $ al 30/06/2026
Albert Grifols Coma-Cros currently works at Grifols SA, as Director from 2024.
Mr. Coma-Cros also formerly worked at Grifols Worldwide Operations Ltd., as President & Managing Director from 2018 to 2020.
Mr. Coma-Cros received his undergraduate degree in 2004 from Autonomous University of Barcelona.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GRIFOLS, S.A. CLASS A 0,02 % | 17/04/2026 | 66.000 ( 0,02 % ) | 676 102 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GRIFOLS, S.A. | Director/Miembro de la Junta | 19/12/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
Grifols Worldwide Operations Ltd.
Grifols Worldwide Operations Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Director Ejecutivo | 01/01/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Grifols SA
Grifols SA Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceuticals, diagnostic and bio supplies | Health Technology |
Autonomous University of Barcelona
Autonomous University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Grifols Worldwide Operations Ltd.
Grifols Worldwide Operations Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.